Skip to content
ClinCalc Pro
Menu
Alpha-2-Delta Ligand — Neuropathic Pain / Epilepsy Adjunct

Gabapentin

Brand names: Neurontin

Gabapentin is a gabapentinoid anticonvulsant used for focal epilepsy and for peripheral neuropathic pain.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing presynaptic calcium influx and the release of excitatory neurotransmitters.

Prescribing in practice

  • Gabapentin is a controlled drug with recognised abuse potential and risk of fatal respiratory depression, especially when combined with opioids or other CNS depressants or in respiratory compromise.
  • Doses require titration to minimise sedation and dizziness, and the dose must be reduced in renal impairment as it is cleared unchanged by the kidneys.
  • Withdraw gradually to avoid rebound seizures and a discontinuation syndrome.

Monitoring

Monitor for sedation, mood or behavioural change including suicidal ideation, and review renal function as a guide to dosing.

Counselling the patient

  • Do not stop suddenly; the dose should be tapered under medical supervision.
  • Avoid alcohol and be cautious with driving until you know how it affects you.
  • Report low mood, thoughts of self-harm or excessive drowsiness.

Evidence & guidelines

MHRA reclassified gabapentin as a controlled drug and has warned of the risk of respiratory depression when combined with other CNS depressants.

Reference: MHRA 2019 Gabapentinoids Controlled Drug Classification; MHRA 2017 Opioid/Gabapentinoid Respiratory Depression Warning; NICE CG173 (Neuropathic Pain); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.